This phase I study was designed to determine the maximum tolerated dose (MTD) and dose-limiting side effects of combination treatment with paclitaxel (Taxol) and UFT (uracil and tegafur in a 4:1 molar ratio) plus oral
Stephanie Lang, MD
Advertisement
Articles by Stephanie Lang, MD
Advertisement
Latest Updated Articles
- Paclitaxel and UFT Plus Oral Calcium Folinate in Pretreated Metastatic Breast Cancer
Published: July 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Niraparib Regimen in BRCA2+ Metastatic CSPC
2
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care
3
Cognitive Function Improvements Highlighted With Acupuncture Use in Breast Cancer
4
The Battle Between MARIPOSA and FLAURA2 Regimens in NSCLC
5
